NewGenIvf Group Limited (NIVF) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    NewGenIvf Group Limited

    NASDAQ: NIVF · Real-Time Price · USD
    1.89
    0.06 (3.28%)
    At close: Sep 09, 2025, 3:13 PM

    NewGenIvf Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 5.43M 5.14M 5.94M 4.12M
    Cost of Revenue
    		 3.61M 3.45M 4.41M 3.09M
    Gross Profit
    		 1.83M 1.68M 1.54M 1.02M
    Operating Income
    		 -1.16M 42.24K -504.91K 198.76K
    Interest Income
    		 6.95K 518.00 21.00 63.00
    Pretax Income
    		 -961K 108.42K 500.65K 156.18K
    Net Income
    		 -525K 130.19K 458.67K -533
    Selling & General & Admin
    		 2.99M 1.64M 1.14M 826.02K
    Research & Development
    		 n/a n/a n/a n/a
    Other Expenses
    		 -186.39K n/a 64.00 n/a
    Operating Expenses
    		 2.8M 1.64M 1.14M 826.02K
    Interest Expense
    		 778.66K 46.18K 77.76K 88.29K
    Selling & Marketing Expenses
    		 206.31K 18.03K 36.19K 24.69K
    Cost & Expenses
    		 6.59M 5.09M 5.54M 3.92M
    Income Tax Expense
    		 -487K -799K 208.14K 294.72K
    Shares Outstanding (Basic)
    		 569.25K 253.73K 193.69K 50.74M
    Shares Outstanding (Diluted)
    		 569.25K 253.73K 193.69K 50.74M
    EPS (Basic)
    		 -23.05 12.85 64.60 -0.01
    EPS (Diluted)
    		 -23.05 12.85 64.60 -0.01
    EBITDA
    		 24.11K 384.31K 725.69K 587.01K
    EBIT
    		 -182K 154.6K 421.75K 244.47K
    Depreciation & Amortization
    		 206.26K 229.71K 303.94K 342.54K

    Add to Watchlist